Altered depth of the olfactory sulcus in ultra high-risk individuals and patients with psychotic disorders

Schizophrenia Research

Volumn 153, Issue 1-3, 2014, Pages 18-24

  Takahashi, Tsutomu ^a   Wood, Stephen J ^b,c   Yung, Alison R ^d,e   Nelson, Barnaby ^d   Lin, Ashleigh ^c   Yücel, Murat ^b,f   Phillips, Lisa J ^b   Nakamura, Yumiko ^a   Suzuki, Michio ^a   Brewer, Warrick J ^d   Proffitt, Tina M ^d   McGorry, Patrick D ^d   Velakoulis, Dennis ^b   Pantelis, Christos ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f MONASH UNIVERSITY   (Australia)

Author keywords

High risk; Magnetic resonance imaging; Neurodevelopment; Olfactory sulcus; Psychosis; Schizophrenia

Indexed keywords

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OLFACTORY GROOVE; OLFACTORY SULCUS DEPTH; OLFACTORY SULCUS LENGTH; OLFACTORY TRACT; POPULATION AND POPULATION RELATED PHENOMENA; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; ULTRA HIGH RISK POPULATION; ADOLESCENT; ANALYSIS OF VARIANCE; HEMISPHERIC DOMINANCE; IMAGE PROCESSING; OLFACTORY BULB; PATHOLOGY; PSYCHOLOGICAL RATING SCALE; RISK; STATISTICS; YOUNG ADULT;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; OLFACTORY BULB; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK; SCHIZOPHRENIA; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 84895813809     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.01.041     Document Type: Article

References (55)

1. Abolmaali N.D., Hietschold V., Vogl T.J., Hüttenbrink K.B., Hummel T. MR evaluation in patients with isolated anosmia since birth or early childhood. Am. J. Neuroradiol. 2002, 23:157-164.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1990, American Psychiatric Press, Washington, DC. Revised Third edition.
3. Andreasen N.C. The Scale for the Assessment of Negative Symptoms (SANS) 1983, The University of Iowa, Iowa City.
4. Andreasen N.C., Liu D., Ziebell S., Vora A., Ho B.C. Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study. Am. J. Psychiatry 2013, 170:609-615.
5. Bechdolf A., Wood S.J., Nelson B., Velakoulis D., Yücel M., Takahashi T., Yung A.R., Berk M., Wong M.T., Pantelis C., McGorry P.D. Amygdala and insula volumes prior to illness onset in bipolar disorder: a magnetic resonance imaging study. Psychiatry Res. 2012, 201:34-39.
6. Brewer W.J., Edwards J., Anderson V., Robinson T., Pantelis C. Neuropsychological, olfactory, and hygiene deficits in men with negative symptom schizophrenia. Biol. Psychiatry 1996, 40:1021-1031.
7. Brewer W.J., Pantelis C., Anderson V., Velakoulis D., Singh B., Copolov D.L., McGorry P.D. Stability of olfactory identification deficits in neuroleptic-naive patients with first-episode psychosis. Am. J. Psychiatry 2001, 158:107-115.
8. Brewer W.J., Wood S.J., McGorry P.D., Francey S.M., Phillips L.J., Yung A.R., Anderson V., Copolov D.L., Singh B., Velakoulis D., Pantelis C. Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. Am. J. Psychiatry 2003, 160:1790-1794.
9. Burón E., Bulbena A. Olfaction in affective and anxiety disorders: a review of the literature. Psychopathology 2013, 46:63-74.
10. Chi J.G., Dooling E.C., Gilles F.H. Gyral development of the human brain. Ann. Neurol. 1977, 1:86-93.
11. Choi J.K., Kang D.H., Park J.Y., Jung W.H., Choi C.H., Chon M.W., Jung M.H., Lee J.M., Kwon J.S. Cavum septum pellucidum in subjects at ultra-high risk for psychosis: compared with first-degree relatives of patients with schizophrenia and healthy volunteers. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1326-1330.
12. Dazzan P., Soulsby B., Mechelli A., Wood S.J., Velakoulis D., Phillips L.J., Yung A.R., Chitnis X., Lin A., Murray R.M., McGorry P.D., McGuire P.K., Pantelis C. Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis. Schizophr. Bull. 2012, 38:1083-1091.
13. Duprez T.P., Rombaux P. Imaging the olfactory tract (cranial nerve #1). Eur. J. Radiol. 2010, 74:288-298.
14. Fatemi S.H., Folsom T.D. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr. Bull. 2009, 35:528-548.
15. Garel C., Chantrel E., Brisse H., Elmaleh M., Luton D., Oury J.F., Sebag G., Hassan M. Fetal cerebral cortex: normal gestational landmarks identified using prenatal MR imaging. AJNR Am. J. Neuroradiol. 2001, 22:184-189.
16. Garner B., Pariante C.M., Wood S.J., Velakoulis D., Phillips L., Soulsby B., Brewer W.J., Smith D.J., Dazzan P., Berger G.E., Yung A.R., van den Buuse M., Murray R., McGorry P.D., Pantelis C. Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol. Psychiatry 2005, 58:417-423.
17. Hummel T., Damm M., Vent J., Schmidt M., Theissen P., Larsson M., Klussmann J.P. Depth of olfactory sulcus and olfactory function. Brain Res. 2003, 975:85-89.
18. Kamath V., Turetsky B.I., Calkins M.E., Kohler C.G., Conroy C.G., Borgmann-Winter K., Gatto D.E., Gur R.E., Moberg P.J. Olfactory processing in schizophrenia, non-ill first-degree family members, and young people at-risk for psychosis. World J. Biol. Psychiatry 2014, (in press). 10.3109/15622975.2011.615862.
19. Kelly P.A., Viding E., Wallace G.L., Schaer M., De Brito S.A., Robustelli B., McCrory E.J. Cortical thickness, surface area, and gyrification abnormalities in children exposed to maltreatment: neural markers of vulnerability?. Biol Psychiatry 2013, 74:845-852.
20. Lieberman J.A., Tollefson G.D., Charles C., Zipursky R., Sharma T., Kahn R.S., Keefe R.S., Green A.I., Gur R.E., McEvoy J., Perkins D., Hamer R.M., Gu H., Tohen M., HGDH Study Group Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch. Gen. Psychiatry 2005, 62:361-370.
21. Mané A., Falcon C., Mateos J.J., Fernandez-Egea E., Horga G., Lomeña F., Bargalló N., Prats-Galino A., Bernardo M., Parellada E. Progressive gray matter changes in first episode schizophrenia: a 4-year longitudinal magnetic resonance study using VBM. Schizophr. Res. 2009, 114:136-143.
22. McGorry P.D., Kaplan I., Dossetor C., Herrman H., Copolov D., Singh B. Royal Park Multidiagnostic Instrument for Psychosis 1989, National Health and Medical Research Council, Melbourne, Australia.
23. McGorry P.D., Yung A.R., Phillips L.J., Yuen H.P., Francey S., Cosgrave E.M., Germano D., Bravin J., McDonald T., Blair A., Adlard S., Jackson H. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch. Gen. Psychiatry 2002, 59:921-928.
24. Mesholam R.I., Moberg P.J., Mahr R.N., Doty R.L. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch. Neurol. 1998, 55:84-90.
25. Nelson B., Yuen H.P., Wood S., Lin A., Spiliotacopoulos D., Bruxner A., Broussard C., Simmons M., Foley D.L., Brewer W.J., Francey S.M., Amminger G.P., Thompson A., McGorry P.D., Yung A.R. Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study. JAMA Psychiatry 2013, 70:793-802.
26. Nguyen A.D., Pelavin P.E., Shenton M.E., Chilakamarri P., McCarley R.W., Nestor P.G., Levitt J.J. Olfactory sulcal depth and olfactory bulb volume in patients with schizophrenia: an MRI study. Brain Imaging Behav. 2011, 5:252-261.
27. Pantelis C., Yücel M., Wood S.J., Velakoulis D., Sun D., Berger G., Stuart G.W., Yung A., Phillips L., McGorry P.D. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr. Bull. 2005, 31:672-696.
28. Pantelis C., Velakoulis D., Wood S.J., Yücel M., Yung A.R., Phillips L.J., Sun D.Q., McGorry P.D. Neuroimaging and emerging psychotic disorders: the Melbourne ultra-high risk studies. Int. Rev. Psychiatry 2007, 19:371-381.
29. Penttilä J., Paillére-Martinot M.L., Martinot J.L., Mangin J.F., Burke L., Corrigall R., Frangou S., Cachia A. Global and temporal cortical folding in patients with early-onset schizophrenia. J. Am. Acad. Child. Adolesc. Psychiatry 2008, 47:1125-1132.
30. Rakic P., Yakovlev P.I. Development of the corpus callosum and cavum septi in man. J. Comp. Neurol. 1968, 132:45-72.
31. Rhoades H.M., Overall J.E. The semistructured BPRS interview and rating guide. Psychopharmacol. Bull. 1988, 24:101-104.
32. Rombaux P., Grandin C., Duprez T. How to measure olfactory bulb volume and olfactory sulcus depth?. B-ENT 2009, 5(Suppl. 13):53-60.
33. Rosales R.K., Lemay M.J., Yakovley P.I. The development and involution of massa intermedia with regard to age and sex. J. Neuropathol. Exp. Neurol. 1968, 27:166.
34. Shaw C.M., Alvord E.C. Cava septi pellucidi et vergae: their normal and pathological states. Brain 1969, 92:213-223.
35. Spitzer R.L., Williams J.B., Gibbon M., First M.B. Structured Clinical Interview for DSM-III-R, Patient Edition (SCID-P) 1990, American Psychiatric Press, Washington, DC.
36. Sun D., Phillips L., Velakoulis D., Yung A., McGorry P.D., Wood S.J., van Erp T.G., Thompson P.M., Toga A.W., Cannon T.D., Pantelis C. Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr. Res. 2009, 108:85-92.
37. Sun D., Stuart G.W., Jenkinson M., Wood S.J., McGorry P.D., Velakoulis D., van Erp T.G., Thompson P.M., Toga A.W., Smith D.J., Cannon T.D., Pantelis C. Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Mol. Psychiatry 2009, 14:976-986.
38. Takahashi T., Yücel M., Yung A.R., Wood S.J., Phillips L.J., Berger G.E., Ang A., Soulsby B., McGorry P.D., Suzuki M., Velakoulis D., Pantelis C. Adhesio interthalamica in individuals at high-risk for developing psychosis and patients with psychotic disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1708-1714.
39. Takahashi T., Yung A.R., Yücel M., Wood S.J., Phillips L.J., Harding I.H., Soulsby B., McGorry P.D., Suzuki M., Velakoulis D., Pantelis C. Prevalence of large cavum septi pellucidi in ultra high-risk individuals and patients with psychotic disorders. Schizophr. Res. 2008, 105:236-244.
40. Takahashi T., Nakamura Y., Nakamura K., Ikeda E., Furuichi A., Kido M., Kawasaki Y., Noguchi K., Seto H., Suzuki M. Altered depth of the olfactory sulcus in first-episode schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 40:167-172.
41. Takahashi T., Nakamura Y., Nakamura K., Nishiyama S., Ikeda E., Furuichi A., Kido M., Noguchi K., Suzuki M. Altered depth of the olfactory sulcus in subjects at risk of psychosis. Schizophr. Res. 2013, 149:186-187.
42. Turetsky B.I., Moberg P.J., Yousem D.M., Doty R.L., Arnold S.E., Gur R.E. Reduced olfactory bulb volume in patients with schizophrenia. Am. J. Psychiatry 2000, 157:828-830.
43. Turetsky B.I., Moberg P.J., Arnold S.E., Doty R.L., Gur R.E. Low olfactory bulb volume in first-degree relatives of patients with schizophrenia. Am. J. Psychiatry 2003, 160:703-708.
44. Turetsky B.I., Crutchley P., Walker J., Gur R.E., Moberg P.J. Depth of the olfactory sulcus: a marker of early embryonic disruption in schizophrenia?. Schizophr. Res. 2009, 115:8-11.
45. Turetsky B.I., Hahn C.G., Borgmann-Winter K., Moberg P.J. Scents and nonsense: olfactory dysfunction in schizophrenia. Schizophr. Bull. 2009, 35:1117-1131.
46. Turetsky B.I., Kamath V., Calkins M.E., Brewer W.J., Wood S.J., Pantelis C., Seidman L.J., Malaspina D., Good K.P., Kopala L.C., Moberg P.J. Olfaction and schizophrenia clinical risk status: just the facts. Schizophr. Res. 2012, 139:260-261.
47. van Haren N.E., Schnack H.G., Cahn W., van den Heuvel M.P., Lepage C., Collins L., Evans A.C., Hulshoff Pol H.E., Kahn R.S. Changes in cortical thickness during the course of illness in schizophrenia. Arch. Gen. Psychiatry 2011, 68:871-880.
48. Velakoulis D., Pantelis C., McGorry P.D., Dudgeon P., Brewer W., Cook M., Desmond P., Bridle N., Tierney P., Murrie V., Singh B., Copolov D. Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study. Arch. Gen. Psychiatry 1999, 56:133-141.
49. Velakoulis D., Wood S.J., Wong M.T., McGorry P.D., Yung A., Phillips L., Smith D., Brewer W., Proffitt T., Desmond P., Pantelis C. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch. Gen. Psychiatry 2006, 63:139-149.
50. Wang J., You H., Liu J.F., Ni D.F., Zhang Z.X., Guan J. Association of olfactory bulb volume and olfactory sulcus depth with olfactory function in patients with Parkinson disease. AJNR Am. J. Neuroradiol. 2011, 32:677-681.
51. Yücel M., Stuart G.W., Maruff P., Wood S.J., Savage G.R., Smith D.J., Crowe S.F., Copolov D.L., Velakoulis D., Pantelis C. Paracingulate morphologic differences in males with established schizophrenia: a magnetic resonance imaging morphometric study. Biol. Psychiatry 2002, 52:15-23.
52. Yücel M., Wood S.J., Phillips L.J., Stuart G.W., Smith D.J., Yung A., Velakoulis D., McGorry P.D., Pantelis C. Morphology of the anterior cingulate cortex in young men at ultra-high risk of developing a psychotic illness. Br. J. Psychiatry 2003, 182:518-524.
53. Yung A.R., Phillips L.J., Yuen H.P., Francey S.M., McFarlane C.A., Hallgren M., McGorry P.D. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr. Res. 2003, 60:21-32.
54. Yung A.R., Phillips L.J., Yuen H.P., McGorry P.D. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr. Res. 2004, 67:131-142.
55. Yung A.R., Phillips L.J., McGorry P.D. Treating Schizophrenia in the Prodromal Phase 2004, Taylor & Francis, London.